O. Bayrou

562 total citations
23 papers, 319 citations indexed

About

O. Bayrou is a scholar working on Dermatology, Rheumatology and Immunology and Allergy. According to data from OpenAlex, O. Bayrou has authored 23 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Dermatology, 7 papers in Rheumatology and 7 papers in Immunology and Allergy. Recurrent topics in O. Bayrou's work include Contact Dermatitis and Allergies (10 papers), Urticaria and Related Conditions (6 papers) and Drug-Induced Adverse Reactions (4 papers). O. Bayrou is often cited by papers focused on Contact Dermatitis and Allergies (10 papers), Urticaria and Related Conditions (6 papers) and Drug-Induced Adverse Reactions (4 papers). O. Bayrou collaborates with scholars based in France, Netherlands and Ireland. O. Bayrou's co-authors include F Leynadier, C. Pecquet, Michel Laurière, Catherine Pecquet, Nadia Raison‐Peyron, Martine Vigan, Jacques Snégaroff, M.-F. Avril, J. C. Guillaume and M Prade and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of the American Academy of Dermatology and Contact Dermatitis.

In The Last Decade

O. Bayrou

19 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. Bayrou France	9	157	122	54	54	39	23	319
Mehrnaz Mesdaghi Iran	12	59 0.4×	117 1.0×	10 0.2×	29 0.5×	39 1.0×	47	338
Simon Tucker United Kingdom	9	80 0.5×	18 0.1×	11 0.2×	44 0.8×	8 0.2×	17	246
Theresa N. Canavan United States	9	115 0.7×	3 0.0×	79 1.5×	195 3.6×	65 1.7×	21	438
J Astruc France	10	44 0.3×	87 0.7×	20 0.4×	77 1.4×	9 0.2×	39	325
David L. Shriner United States	7	258 1.6×	10 0.1×	164 3.0×	254 4.7×	17 0.4×	10	506
Tae Won Song South Korea	13	120 0.8×	271 2.2×	12 0.2×	29 0.5×	15 0.4×	33	554
Winfried Klövekorn Germany	11	238 1.5×	21 0.2×	25 0.5×	88 1.6×	13 0.3×	20	325
R. Lindblad United States	8	22 0.1×	179 1.5×	122 2.3×	44 0.8×	5 0.1×	18	436
Eva‐Maria Varga Austria	11	584 3.7×	1.1k 9.4×	24 0.4×	11 0.2×	16 0.4×	17	1.3k
Sabita Islam United Kingdom	11	156 1.0×	868 7.1×	32 0.6×	19 0.4×	28 0.7×	14	1.0k

Countries citing papers authored by O. Bayrou

Since Specialization

Citations

This map shows the geographic impact of O. Bayrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Bayrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Bayrou more than expected).

Fields of papers citing papers by O. Bayrou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Bayrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Bayrou. The network helps show where O. Bayrou may publish in the future.

Co-authorship network of co-authors of O. Bayrou

This figure shows the co-authorship network connecting the top 25 collaborators of O. Bayrou. A scholar is included among the top collaborators of O. Bayrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Bayrou. O. Bayrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amsler, E., et al.. (2019). Traitement de l’urticaire chronique par omalizumab : données en vie réelle. Annales de Dermatologie et de Vénéréologie. 146(1). 9–18.

Amsler, E., Jean‐Eric Autegarden, O. Bayrou, et al.. (2019). Manifestations cutanées aux antihistaminiques anti-H1. Revue française d'allergologie. 59(3). 258–258.

Bayrou, O., et al.. (2015). Allergic contact dermatitis caused by methylisothiazolinone in hair gel. Contact Dermatitis. 73(6). 364–366. 7 indexed citations

Amsler, E., O. Bayrou, C. Pecquet, & C. Francès. (2012). Five Cases of Contact Dermatitis to a Trendy Pet. Dermatology. 224(4). 292–294. 4 indexed citations

Bogiatzi, Sofia I., Maude Guillot‐Delost, Antonio Cappuccio, et al.. (2012). Multiple-checkpoint inhibition of thymic stromal lymphopoietin–induced TH2 response by TH17-related cytokines. Journal of Allergy and Clinical Immunology. 130(1). 233–240.e5. 25 indexed citations

Basketter, David A., A. Pons-Guiraud, Arian van Asten, et al.. (2010). Fragrance allergy: assessing the safety of washed fabrics. Contact Dermatitis. 62(6). 349–354. 4 indexed citations

Laurière, Michel, Catherine Pecquet, Jacques Snégaroff, et al.. (2006). Hydrolysed wheat proteins present in cosmetics can induce immediate hypersensitivities. Contact Dermatitis. 54(5). 283–289. 88 indexed citations

Bayrou, O., et al.. (2005). Head and Neck Atopic Dermatitis and <i>Malassezia-furfur</i>-Specific IgE Antibodies. Dermatology. 211(2). 107–113. 36 indexed citations

Pecquet, Catherine, O. Bayrou, M. Vigan, Nicholas Raison, & Michel Laurière. (2004). P14 Hydrolysed wheat protein: a new allergen in cosmetics and food. Contact Dermatitis. 50(3). 182–183. 12 indexed citations

10.

Mathelier‐Fusade, P., et al.. (2003). [Chronic urticaria, thyroiditis and autologous serum test].. PubMed. 130(12 Pt 1). 1115–8. 9 indexed citations

11.

Mathelier‐Fusade, P., et al.. (2002). Chronic urticaria (CU), thyroid disease (TD) and the autologous serum test (AST). Journal of Allergy and Clinical Immunology. 109(1). S124–S124. 1 indexed citations

12.

Vermeulen, Cornelis J., P. Mathelier‐Fusade, O. Bayrou, et al.. (2002). Response of basophils to autologous serum from patients with chronic urticaria. Journal of Allergy and Clinical Immunology. 109(1). S88–S88. 1 indexed citations

13.

Bayrou, O., H. Gaouar, & F Leynadier. (2000). Famciclovir as a possible alternative treatment in some cases of allergy to acyclovir. Contact Dermatitis. 42(1). 42–55. 10 indexed citations

14.

Doutre, M.‐S., P. Mathelier‐Fusade, J Meynadier, & O. Bayrou. (2000). Quoi de neuf dans l'urticaire chronique ?. Revue Française d Allergologie et d Immunologie Clinique. 40(5). 560–571. 1 indexed citations

15.

Autegarden, Jean‐Eric, et al.. (1999). Anaphylactic shock after application of chlorhexidine to unbroken skin. Contact Dermatitis. 40(4). 215–215. 37 indexed citations

16.

Bayrou, O.. (1993). Epidemiology of type IV allergies to rubber chemical additives. Clinical Reviews in Allergy. 11(3). 421–425. 1 indexed citations

17.

Bayrou, O., et al.. (1993). Adult Kawasaki syndrome associated with HIV infection and anticardiolipin antibodies. Journal of the American Academy of Dermatology. 29(4). 663–664. 22 indexed citations

18.

Bayrou, O., et al.. (1992). [Kawasaki syndrome in adults with perineal eruption].. PubMed. 119(11). 839–40. 1 indexed citations

19.

Bayrou, O., et al.. (1991). Primary neuroendocrine carcinoma of the skin. Journal of the American Academy of Dermatology. 24(2). 198–207. 54 indexed citations

20.

Bayrou, O., et al.. (1990). [Birt-Hogg-Dubé syndrome. Fibrofolliculoma, trichodiscoma and acrochordon].. PubMed. 117(1). 37–41. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact